Genelux Financial Statements From 2010 to 2025

GNLX Stock   3.58  0.15  4.02%   
Genelux Common financial statements provide useful quarterly and yearly information to potential Genelux Common investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Genelux Common financial statements helps investors assess Genelux Common's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Genelux Common's valuation are summarized below:
Gross Profit
K
Market Capitalization
117.4 M
Enterprise Value Revenue
10.7 K
Revenue
K
Earnings Share
(0.94)
We have found one hundred twenty available fundamental trends for Genelux Common, which can be analyzed and compared to other ratios and to its competitors. All investors should make sure to confirm all of Genelux Common regular market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road. Market Cap is likely to rise to about 323.4 M in 2025, whereas Enterprise Value is likely to drop slightly above 160.2 M in 2025.

Genelux Common Total Revenue

185,725

Check Genelux Common financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Genelux Common's main balance sheet or income statement drivers, such as Depreciation And Amortization of 883.5 K, Interest Expense of 4.8 M or Other Operating Expenses of 16.8 M, as well as many indicators such as Price To Sales Ratio of 1.9 K, Dividend Yield of 0.0 or PTB Ratio of 16.61. Genelux financial statements analysis is a perfect complement when working with Genelux Common Valuation or Volatility modules.
  
Check out the analysis of Genelux Common Correlation against competitors.
For more information on how to buy Genelux Stock please use our How to Invest in Genelux Common guide.

Genelux Common Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets33.7 M32.1 M9.6 M
Slightly volatile
Short and Long Term Debt Total2.2 M2.3 M16.5 M
Slightly volatile
Other Current Liabilities1.8 M1.9 MM
Slightly volatile
Total Current Liabilities7.2 M7.5 M14.8 M
Pretty Stable
Property Plant And Equipment Net2.8 M4.1 M2.7 M
Slightly volatile
Accounts Payable4.9 M4.4 MM
Slightly volatile
Cash5.7 M10.8 M2.9 M
Slightly volatile
Non Current Assets Total3.3 M4.2 M2.9 M
Slightly volatile
Non Currrent Assets Other100.5 K105.8 K183.1 K
Pretty Stable
Other Assets92.4 K105.8 K84.6 K
Slightly volatile
Cash And Short Term Investments28 M26.7 M6.1 M
Slightly volatile
Common Stock Shares Outstanding26.4 M28.1 M24.2 M
Slightly volatile
Liabilities And Stockholders Equity33.7 M32.1 M9.6 M
Slightly volatile
Non Current Liabilities Total1.6 M1.7 M11.8 M
Slightly volatile
Other Current Assets899.1 K1.2 M455.2 K
Slightly volatile
Other Stockholder Equity181.1 M277.1 M153.1 M
Slightly volatile
Total Liabilities7.2 M7.6 M26.5 M
Slightly volatile
Total Current Assets29.2 M27.8 M6.6 M
Slightly volatile
Accumulated Other Comprehensive Income16.9 K16.1 K4.6 K
Slightly volatile
Short Term Debt713.4 K751 K4.7 M
Very volatile
Common Stock17.2 K31.1 K21.4 K
Slightly volatile
Property Plant EquipmentMM2.5 M
Slightly volatile
Long Term Debt12.9 M7.7 M18.4 M
Slightly volatile
Capital Lease Obligations1.6 M2.9 M1.1 M
Slightly volatile
Property Plant And Equipment Gross5.7 M8.1 M4.9 M
Slightly volatile
Short and Long Term Debt9.6 M18.9 M6.7 M
Slightly volatile
Capital Stock24 K24.3 K29.9 K
Slightly volatile
Current Deferred Revenue145.3 K153 K3.4 M
Slightly volatile
Deferred Long Term Liabilities1.3 M1.4 M1.5 M
Slightly volatile

Genelux Common Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization883.5 K1.2 M647.7 K
Slightly volatile
Interest Expense4.8 M4.6 M1.6 M
Slightly volatile
Other Operating Expenses16.8 M28 M13.7 M
Slightly volatile
Research Development9.2 M14.7 M8.4 M
Slightly volatile
Cost Of Revenue883.5 K1.2 M647.7 K
Slightly volatile
Total Operating Expenses16.7 M28 M13.4 M
Slightly volatile
Selling General Administrative8.5 M13.3 M7.2 M
Slightly volatile
Reconciled Depreciation985 K1.2 M773 K
Slightly volatile
Income Tax Expense917.6 K765.1 K1.2 M
Slightly volatile
Selling And Marketing Expenses814.4 K916.2 K998.9 K
Slightly volatile

Genelux Common Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow433.7 K456.6 K2.1 M
Pretty Stable
Depreciation883.5 K1.2 M647.7 K
Slightly volatile
Capital Expenditures466.2 K922.5 K1.3 M
Slightly volatile
End Period Cash Flow5.7 M10.8 M2.9 M
Slightly volatile
Change To Netincome3.2 M1.9 M3.6 M
Slightly volatile
Stock Based Compensation3.4 M4.7 M4.9 M
Slightly volatile
Issuance Of Capital Stock47.9 M45.6 M15.4 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.9 K1.8 K369
Slightly volatile
Stock Based Compensation To Revenue28.9327.555.6205
Slightly volatile
Capex To Depreciation1.321.162.5466
Slightly volatile
EV To Sales1.9 K1.8 K364
Slightly volatile
Payables Turnover0.160.240.1853
Slightly volatile
Sales General And Administrative To Revenue64.361.2412.4665
Slightly volatile
Research And Ddevelopement To Revenue70.9767.5914.0202
Slightly volatile
Capex To Revenue5.75.431.0761
Slightly volatile
Cash Per Share0.90.850.2229
Slightly volatile
Days Payables Outstanding2.1 K1.6 KK
Pretty Stable
Income Quality0.470.640.6033
Pretty Stable
Current Ratio3.493.320.7492
Slightly volatile
Capex Per Share0.03290.04830.0549
Slightly volatile
Revenue Per Share0.00760.0080.3677
Slightly volatile
Interest Debt Per Share0.290.310.7636
Slightly volatile
Debt To Assets0.09870.14.0507
Slightly volatile
Days Of Payables Outstanding2.1 K1.6 KK
Pretty Stable
Ebt Per Ebit0.931.051.0896
Pretty Stable
Quick Ratio3.493.320.7492
Slightly volatile
Net Income Per E B T0.921.141.1042
Pretty Stable
Cash Ratio1.361.290.3357
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.191.211.1833
Slightly volatile
Fixed Asset Turnover0.05160.05434.5537
Slightly volatile
Debt Ratio0.09870.14.0507
Slightly volatile
Price Sales Ratio1.9 K1.8 K369
Slightly volatile
Asset Turnover0.00670.0071.6271
Slightly volatile

Genelux Common Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap323.4 M308 M179.2 M
Slightly volatile
Enterprise Value160.2 M301.8 M183 M
Slightly volatile

Genelux Fundamental Market Drivers

Cash And Short Term Investments23.2 M

Genelux Upcoming Events

13th of February 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View
13th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Genelux Common Financial Statements

Genelux Common investors use historical fundamental indicators, such as Genelux Common's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Genelux Common. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue153 K145.3 K
Cost Of Revenue1.2 M883.5 K
Total Revenue195.5 K185.7 K
Stock Based Compensation To Revenue 27.55  28.93 
Sales General And Administrative To Revenue 61.24  64.30 
Research And Ddevelopement To Revenue 67.59  70.97 
Capex To Revenue 5.43  5.70 
Revenue Per Share 0.01  0.01 
Ebit Per Revenue(163.47)(155.30)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Genelux Stock Analysis

When running Genelux Common's price analysis, check to measure Genelux Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genelux Common is operating at the current time. Most of Genelux Common's value examination focuses on studying past and present price action to predict the probability of Genelux Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genelux Common's price. Additionally, you may evaluate how the addition of Genelux Common to your portfolios can decrease your overall portfolio volatility.